Business
Context Therapeutics Inc (NASDAQ: CNTX) Has Been Falling -46.31% Year-To-Date. Troubles Yet To Come?
During the last session, Context Therapeutics Inc (NASDAQ:CNTX)’s traded shares were 0.17 million, with the beta value of the company hitting 1.86. At the end